RNA tech firm GreenLight Biosciences to go public in $1.5 billion SPAC deal.
University of Auckland leads project to combat RSV, flu by applying Covid-19 lessons.
How COVID is changing the study of human behavior
So your kid barely had the sniffles this past year. Will that last?
These scientists are already on the hunt for the next pandemic
Preventing the next pandemic
Early data suggest wearables can catch COVID-19 cases before symptoms emerge
Amid one pandemic, students train for the next one
The pandemic is rewriting the rules of science
Flu shots for kids protect everybody, study shows
How data became one of the most powerful tools to fight an epidemic
GreenLight Biosciences raises $17m to ramp mRNA production for COVID-19 vaccine candidate trials
The search for a universal flu vaccine heats up
Experts debate urgency of better flu shot, drug prices, nonprofit R&D models
University of Cambridge’s Prof Jonathan Heeney answers call to transform flu vaccine
Oregon Health & Science University doc dreams of lifetime immunity with one flu shot
UChicago-Led Effort Receives Grant For Research Developing Universal Influenza Vaccine
New partnership announced to expand the publication of null and negative influenza research findings and support replication studies.
With new grants, Flu Lab and Gates Foundation take an early step toward a universal flu vaccine
New report calls for an urgent, coordinated effort to amplify and focus resources on universal influenza vaccine development.